Cares more about money than lives - Junior Data Analyst Tempus AI Employee Review

1.0
Apr 29, 2019
Recommend
CEO approval
Business outlook

Pros

Daily Fooda stipend, free coffee/barista, unlimited (mostly unhealthy) snacks

Cons

As a JDA, we are constantly being hounded by management to abstract a certain number of cases every week and are threatened that we’ll receive a warning, which leads to a performance improvement plan (PIP), if we do not meet the goal. We are also expected to meet a QA goal of only 80%, and only 10% of cases are QA’d by your lead. Therefore, the rules of abstraction and QA are at your lead’s discretion, and many fields are coded inconsistently amongst leads and cancer subtypes. This data is being used to help cancer patients and only 10% of it has its quality checked by managers with subjective rules. JDAs are undervalued and given minimal incentive or aid to succeed. We’ve all graduated with at least a 4-year degree and were hired to be data ANALYSTS, but all they’re having us do is read through oncology documents and code things such as diagnosis, treatments, and outcomes. We’re expected to work overtime to meet goals but do not receive OT pay or any additional bonuses. If you go above and beyond and/or suck up to the leads, they’ll promote you to DA. As a DA, you’ll receive more work but the same pay, so there isn’t really an incentive to get promoted. On the other hand, if you don’t meet the quality and quantity goals every week, you’ll be put on a PIP where you won’t receive any additional training but are expected to improve in 4 weeks or be terminated. Additionally, management tracks your hours to ensure you’re working 40 hour weeks without taking into account meetings, bathroom breaks, etc. If you do happen to meet your goal before the week is over, you aren’t allowed to help teammates who have gotten more difficult cases meet their goal. The leads have no previous experience managing people, and it really shows. They’ve been caught complaining about JDAs by ear as well as over a public Slack channel, they show favoritism, and most of them look away when they see you walking down the hall rather than saying “hi”. They don’t know how to establish healthy, professional relationships with their employees or how to communicate properly. They also like to make up their own department rules that don’t apply to the rest of the company, such as no unlimited PTO and you have to wait one year before transferring departments. Overall, working as a JDA has been the worst job experience I’ve had, with the worst managers I’ve had. I would not recommend this job to anyone, especially if you’re looking to gain new skills. You will be disrespected by the entire company and have an unhealthy work life.

Explore other reviews about Tempus AI

5.0
Jul 4, 2026
Recommend
CEO approval
Business outlook

Pros

Good place to work at, very impactful work.

Cons

No cons i can think of tbh.

2.0
Mar 12, 2026
Recommend
CEO approval
Business outlook

Pros

As mentioned work is great since it is cancer research and my coworkers are amazing. Immediate leadership managers and Sr. managers are good as well but somewhat unorganised. Work life balance is good also and health insurance as long as you get BCBS PPO with copay otherwise you're screwed paying off deductible.

Cons

Pay is below industry average, and there is essentially no room to negotiate a better raise. Employees are actively discouraged from discussing compensation, and whatever leadership decides is final, there are no exceptions. If you try to escalate concerns or request a conversation with senior leadership, such as a senior director or VP, you’ll quickly find yourself getting the runaround. Leadership prefers to hide behind layers of management rather than engage directly. There is also no clear or transparent path for career advancement. Opportunities technically exist, but they are extremely limited. You can do everything right, receive a top rating of 5 on your annual performance review, and still not be promoted to manager or see any meaningful improvement in compensation. To make matters worse, the billionaire CEO and founder has said things like, “Don’t worry about pay because we’re curing cancer.” Statements like that feel incredibly out of touch when employees are earning $50k–$60k a year and receiving annual raises of only about $2,000. On top of that, equity is almost impossible to obtain. You have to fight for even the possibility of it, because stock or equity compensation is reserved almost exclusively for the C-suite and directors, with virtually nothing available for employees below that level.

2
See reviews by: Helpful|Rating|Date|All